Cigna Group $CI Position Decreased by Resona Asset Management Co. Ltd.

Resona Asset Management Co. Ltd. decreased its holdings in shares of Cigna Group (NYSE:CIFree Report) by 4.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 86,629 shares of the health services provider’s stock after selling 3,681 shares during the period. Resona Asset Management Co. Ltd.’s holdings in Cigna Group were worth $23,855,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently made changes to their positions in the business. Aviance Capital Partners LLC boosted its position in shares of Cigna Group by 2.0% during the 4th quarter. Aviance Capital Partners LLC now owns 19,760 shares of the health services provider’s stock valued at $5,438,000 after purchasing an additional 384 shares in the last quarter. Profund Advisors LLC boosted its position in shares of Cigna Group by 26.1% during the 4th quarter. Profund Advisors LLC now owns 4,345 shares of the health services provider’s stock valued at $1,196,000 after purchasing an additional 900 shares in the last quarter. ProShare Advisors LLC boosted its stake in shares of Cigna Group by 13.2% during the 4th quarter. ProShare Advisors LLC now owns 54,247 shares of the health services provider’s stock worth $14,930,000 after acquiring an additional 6,332 shares in the last quarter. Stronghold Wealth Management L.L.C. bought a new stake in shares of Cigna Group during the 4th quarter worth $258,000. Finally, Entrust Financial LLC bought a new stake in shares of Cigna Group during the 4th quarter worth $42,000. Institutional investors own 86.99% of the company’s stock.

Cigna Group Stock Performance

Shares of Cigna Group stock opened at $291.37 on Wednesday. The stock has a market cap of $77.08 billion, a PE ratio of 12.35, a price-to-earnings-growth ratio of 1.00 and a beta of 0.30. The business has a fifty day simple moving average of $275.45 and a 200-day simple moving average of $275.51. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.69. Cigna Group has a 12 month low of $239.51 and a 12 month high of $338.89.

Cigna Group (NYSE:CIGet Free Report) last issued its earnings results on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, topping the consensus estimate of $7.60 by $0.19. The business had revenue of $68.52 billion during the quarter, compared to analysts’ expectations of $66.29 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.Cigna Group’s revenue was up 4.6% compared to the same quarter last year. During the same quarter last year, the firm posted $6.74 earnings per share. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, sell-side analysts anticipate that Cigna Group will post 30.39 EPS for the current fiscal year.

Cigna Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Investors of record on Thursday, June 4th will be issued a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a dividend yield of 2.1%. The ex-dividend date is Thursday, June 4th. Cigna Group’s dividend payout ratio (DPR) is currently 26.45%.

Insider Buying and Selling

In related news, insider Nicole S. Jones sold 2,307 shares of the firm’s stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $666,515.37. Following the completion of the sale, the insider directly owned 32,647 shares in the company, valued at approximately $9,432,044.77. This trade represents a 6.60% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Everett Neville sold 1,719 shares of the firm’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $496,636.29. Following the sale, the insider owned 5,670 shares of the company’s stock, valued at approximately $1,638,119.70. This represents a 23.26% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 205,904 shares of company stock worth $60,277,068. 0.60% of the stock is owned by company insiders.

Analyst Ratings Changes

CI has been the subject of several research reports. Truist Financial raised their price objective on Cigna Group from $320.00 to $350.00 and gave the stock a “buy” rating in a research note on Tuesday, February 17th. UBS Group reissued a “buy” rating and set a $375.00 price objective on shares of Cigna Group in a research note on Monday, February 9th. Sanford C. Bernstein raised their price objective on Cigna Group from $358.00 to $371.00 and gave the stock an “outperform” rating in a research note on Tuesday, May 5th. Wall Street Zen upgraded shares of Cigna Group from a “hold” rating to a “buy” rating in a report on Saturday, February 7th. Finally, Cantor Fitzgerald raised their target price on shares of Cigna Group from $325.00 to $340.00 and gave the stock an “overweight” rating in a report on Friday, May 1st. One research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $338.35.

Read Our Latest Research Report on CI

Cigna Group Company Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

See Also

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.